VIROPHARMA INC
VPHM
VPHM was delisted on the 23rd of January, 2014.
0 hedge funds and large institutions have $0 invested in VIROPHARMA INC in 2014 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 169 closing their positions.
100% less funds holding
Funds holding: 172 → 0 (-172)
100% less funds holding in top 10
Funds holding in top 10: 11 → 0 (-11)
100% less capital invested
Capital invested by funds: $3.29B → $0 (-$3.29B)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 169
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$477M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$205M |
| 3 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$188M |
| 4 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
-$153M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
-$142M |
VPHM Hedge Fund Activity: Q1 2014 in Review
0 of the 3,475 institutional investors tracked by Wall St. Rank reported a position in VIROPHARMA INC (VPHM) for Q1 2014, worth a combined $0 — down 100% from $3.29B a quarter earlier.
Sellers outnumbered buyers: 169 funds closed out of VPHM and 0 opened new positions — a net loss of 169 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Fidelity Investments, exiting entirely with an estimated $477M sold.
- 0 institutional investors held VIROPHARMA INC (VPHM) as of Q1 2014, down from 172 in Q4 2013.
- Funds reported $0 of VIROPHARMA INC stock for Q1 2014, down 100% quarter-over-quarter.
- 0 funds opened new VIROPHARMA INC positions in Q1 2014 and 169 closed out, a net change of -169 holders.
- The largest VIROPHARMA INC seller in Q1 2014 was Fidelity Investments, an estimated $477M sold.
Based on aggregated 13F filings for Q1 2014.